Leaflet CLINDAMYCIN 300mg / 2ml solution for injection


Indicated for: bacterial infections

Route of administration: injectable

Substance: clindamycin (lincosamide antibiotic)

ATC: J01FF01 (Antiinfectives for systemic use | Macrolides, lincosamides and streptogramins | Lincosamides)

Clindamycin is an antibiotic used to treat a wide range of bacterial infections, including skin, bone, joint, and respiratory tract infections. It works by inhibiting bacterial protein synthesis, thereby stopping bacterial growth.

The medication is available in the form of capsules, injectable solutions, or topical gels, depending on the type and severity of the infection. It is important to follow your doctor's instructions and complete the full course of treatment to prevent the development of bacterial resistance.

Side effects may include nausea, diarrhea, abdominal pain, or skin rashes. In rare cases, clindamycin use may lead to pseudomembranous colitis, a serious condition requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver or kidney diseases, to ensure the safe use of clindamycin.

General data about CLINDAMYCIN 300mg / 2ml

  • Substance: clindamycin
  • Date of last drug list: 01-05-2026
  • Commercial code: W51317001
  • Concentration: 300mg / 2ml
  • Pharmaceutical form: solution for injection
  • Packing volume: 2 ml
  • Product type: generic
  • Price: 65.90 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: STADA M&D S.R.L. - ROMANIA
  • Holder: STADA HEMOFARM S.R.L. - ROMANIA
  • Number: 8969/2016/01
  • Shelf life: 2 years

Concentrations available for clindamycin

  • 100mg
  • 150mg
  • 150mg/ml
  • 300mg
  • 300mg/2ml
  • 600mg